Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macular Degeneration

Figure 1

Systemic VEGF-A levels of patients with AMD or DR at baseline and at one week and four weeks after aflibercept administration.